GlassScriptPhysician profile
Sneha Lad
NPI 1477046746
$3,798.09
in general payments reported to CMS, 2019-2025
8 companies · $304 in 2025
The $304 reported for 2025 was more than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $469 · 2022: $1,830 · 2023: $631 · 2024: $564 · 2025: $304.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,499.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,499.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,991.00 | 2021-2025 | Linq II, Aurora Ev-Icd Mri Surescan, Pulseselect |
| Abbott Laboratories | $595.07 | 2021-2025 | Jot Dx, Aveir, Gallant |
| Boston Scientific Corporation | $473.89 | 2023-2024 | Lux-Dx Insertable Cardiac Monitor, Ingevity+, Emblem Mri S-Icd |
| Biotronik INC. | $296.04 | 2021-2025 | Biomonitor, Amvia Edge |
| Biosense Webster, INC. | $274.15 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $105.74 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $42.85 | 2021 | |
| Philips North America LLC | $19.35 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sneha Lad listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.